Proud to announce Philippe Capart to our executive team
Medimix International is proud to announce a new addition to its executive team.
Philippe Capart, Senior Vice President Commercial Operations has joined Medimix global headquarters starting January 15th.
With 20 years of professional experience in various pharmaceutical companies (AbbVie, AstraZeneca, BMS…), Philippe brings breadth and depth to support Medimix sustained growth among key accounts in the industry. His most recent position was Global Marketing Director for Humira, the number one drug in sales worldwide.
Philippe has worked for various billion dollars blockbusters with global or regional positions in the US, Europe and Latin America. His experience reinforces Medimix commitment to provide global executives with tools and insights that enable them to guide the strategy of their teams and brands around the world, bridging the gap between global strategy and local tactics.
Among his duties as Senior Vice President Commercial Operations, Philippe will support the development of Medimix LiveTracker™ in Oncology and Hematology, coordinating the efforts of Medimix Key Account Management and Business Development Teams
“We are very happy to see Philippe joining our global team”, shares Henry Gazay, CEO of Medimix International. “He represents an essential asset for the development of our strategy, as we are experiencing strong continued growth and foresee that it will even accelerate in the coming years. His managerial skills and pharma expertise complement and reinforce our position with the top global pharmaceutical companies. He is a strategic thinker as well as a pragmatic leader, two qualities which provide tremendous added value to the insights which LiveTracker™ brings to our clients.”
“After 20 years in the pharmaceutical industry, I am very excited to join Medimix international,” declares Capart. “Listening to our customers’ voice and developing patient-centric approaches has always been essential to me, as it is the foundation of any successful strategy. In my new role at Medimix, I will support my colleagues in the Pharmaceutical world, helping them inform their Oncology and Hematology product strategies with real-world evidence data. I am delighted to contribute to Medimix’s mission to foster improved patient outcomes, for a better and healthier world.”